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Leuphana University LueneburgEvidence for the impact of psychological Interventions for
subthreshold depression (sD) is conflicting.Moreover, human
resources to deliver such treatments are limited. This studyaimed to evaluate the effectiveness of a web-based interven-
tion with adherence-focused guidance in the treatment of sD.
Participants with sD (CES-D≥ 16, no Major Depressive
Disorder according to DSM-IV criteria,N = 204) recruited via
72 ebert et al .a large health insurance were randomly allocated to a web-
based mobile-supported cognitive-behavioral intervention or
to awaitlist control conditionwith unrestricted access to usual
care. The primary outcome was the reduction in depressive
symptom severity asmeasured by blind diagnostic raters using
the Quick Inventory of Depressive Symptomatology (QIDS)
at posttreatment. There was a statistically significant
between-group difference in QIDS scores at posttreatment in
favor of the intervention group, F(1, 201) = 11.31, p = .001,
corresponding to a medium effect size of d = 0.37 (95%
CI 0.09–0.64) and a NNT of 7 (95%–CI 3.7–41.2).
Significant effects in favour of the intervention group were
also found for secondary outcomes such as quality of life,
anxiety, and insomnia severity. Web-based self-help interven-
tionswith adherence-focused guidance could be an acceptable
and effective approach to reduce a range of negative
consequences associated with subclinical depression.
Keywords: subthreshold depression; minor depression; web-based
intervention; clinician-rated
SUBTHRESHOLD DEPRESSION CAN BE DEFINED dimension-
ally (i.e., scoring above a cutoff level on a validated
self-rated depression screening measure while the
criteria of a full-blown depressive disorder are not
yet met according to a diagnostic interview) or
categorically (i.e., fewer than five symptoms of
depression according to the DSM-IV, for instance,1 Contributed equally.
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Published by Elsevier Ltd. All rights reserved.are present) (Baumeister, 2012; Cuijpers, Koole,
et al., 2014). Subthreshold depression is a highly
prevalent condition (Cuijpers, de Graaf, & van
Dorsselaer, 2004) related to increased mortality
(Cuijpers, Vogelzangs, et al., 2013), poorer quality
of life (Rucci et al., 2003), increased health care
service utilization (Goldney, Fisher, Dal Grande, &
Taylor, 2004), and vast societal costs (Cuijpers
et al., 2007). From a clinical perspective, subthresh-
old depression is not only important because it
can be a disabling condition, but also due to the
associated risk of developing major depression.
Subthreshold depression can be regarded as part of
the prodromal phase of major depression (Eaton,
Badawi, & Melton, 1995). Almost all individuals
who have developed a major depression are
assumed to have initially passed through a period
of subthreshold depression (Frank et al., 1991),
underscoring the importance of preventive inter-
ventions aimed at the treatment of subthreshold
depression and the prevention of major depression.
In contrast to major depressive disorder, however,
there are only a few studies on the effectiveness of
psychological treatments for subthreshold depres-
sion. A recent meta-analysis showed small-to-
moderate effect sizes of psychological interventions
on depressive symptom severity at posttreatment
compared to usual care (Cuijpers, Koole, et al.,
2014). Notwithstanding, the four studies using
clinician-rated outcomes did not indicate significant
positive results. As effects of psychological interven-
tions for the treatment of subthreshold depression
are expected to be small to moderate in size only,
cost-effective delivery modes are particularly needed.
The Internet offers an opportunity to deliver
psychological interventions to a large audience at
lower costs than face-to-face interventions, depend-
ing on the level of human support involved.
The efficacy of web-based interventions for major
depression is very well researched. Treatment effects
for web-based cognitive behavioral therapy for
depression or depressive symptoms are large in size
(SMD 0.94, 95% CI 0.77-1.11; 20 RCTs; Ebert
et al., 2015; Hedman, Ljotsson, & Lindefors, 2012).
Effect sizes at posttreatment range from d = 1.35 for
guided interventions, d = .95 for administrative-
supported interventions, to d = .78 for unguided
interventions (Richards & Richardson, 2012). As
face-to-face psychological interventions show
smaller effects in subthreshold depression compared
to major depression (Cuijpers, Koole, et al., 2014), it
is important to assess the usefulness of web-based
interventions in subthreshold depression. However,
the evidence base for the effectiveness of web-based
interventions in subthreshold depression is still
limited. Three randomized controlled trials have
73web - and mob i le - ba s ed treatment of subthre shold depre s s ionbeen conducted that have tested the efficacy of
web-based interventions in the treatment of sub-
threshold depression (Buntrock et al., 2015;
Buntrock et al., 2016; Imamura et al., 2014; Spek
et al., 2007). Buntrock and colleagues (2015, 2016)
showed that a web-based intervention with intensive
guidance (up to 3 hours per participant) was effective
in treating subthreshold depression and in preventing
the onset of major depressive disorder. However, the
amount of intensive guidance clearly places con-
straints for scaling up this intervention. Therefore,
we evaluated the same web-based intervention with
minimal guidance (i.e., adherence-focused guidance),
as such an intervention may cost less and will be
associated with fewer constraints for scaling up.
The adherence-focused guidance concept was in
line with the supportive accountability model
(Mohr, Cuijpers, & Lehman, 2011). This model
assumes that adherence to a web-based intervention
(and therefore the effectiveness) could be enhanced
via human support through accountability to an
e-coach who is seen as legitimate, trustworthy,
benevolent, and having expertise. The e-coach
guidance consists of two elements: (a) adherence
monitoring and (b) feedback on demand. Both
personal and automatic reminders have shown to
improve adherence to self-guided health promotion
and behavior change interventions (Titov et al.,
2013). However, it is assumed that personal as
opposed to automatic reminders from an e-coach
are perceived as more benevolent and are, therefore,
more effective. Feedback on demand provides
participants with the opportunity to contact an
e-coach via the internal messaging function on the
platform and to receive individual support/feed-
back whenever desired. Feedback is not assumed to
have a direct influence on the effectiveness of the
intervention, but expected to create a sense that the
e-coach is legitimate and has the participant’s best
interest at heart. Individuals are assumed to respond
more positively to adherence demands from an
e-coach who is perceived as legitimate (Ebert et al.,
2016; Tyler, 1997; Zarski et al., 2016). This
guidance format is expected to offer the positive
effects of regular guidance while keeping the time
spent per participant to aminimum, thus producing a
more economic version of the guided web-based
intervention.
This study aimed to evaluate the effectiveness of a
web-based intervention with adherence focused
guidance in the treatment of subthreshold depres-
sion. We hypothesized that the effectiveness of the
web-based intervention with clinician-rated depres-
sive symptom severity at posttreatment as its main
outcome was superior to a waitlist control group
with unrestricted access to usual care.Methods
design
A two-armed, pragmatic single-blind randomized
controlled clinical trial was conducted to compare an
adherence-focused guided web-based intervention
(GET.ON Mood Enhancer) with a waitlist control
condition with unrestricted access to care-as-usual.
Assessments took place at baseline (diagnostic
interviews, online questionnaires), at posttreatment
(7 weeks; diagnostic interviews, online question-
naires), and at 3-month follow-up (online question-
naires only; see Figure 1 for a detailed overview of
assessments). The study was approved by the
Medical Ethics Committee of the University of
Lueneburg (reference number Ebert201404_Depr)
and registered under DRKS00005973 in the German
clinical trial registry.study population and recruitment
Study participants were recruited from the general
population via a large German health insurance
company (BARMER GEK), through newspaper
articles, on-air media, and related websites. Referral
by a GP was not required. The present trial is a
follow-up study of a prevention trial that assessed
the (cost-) effectiveness of the web-based interven-
tion with intensive guidance on the onset of major
depressive disorder. After the enrollment of the first
study was completed, there were still more than 700
applicants on a waitlist for study participation.
Applicants self-identifying with a diminished mood
who (a) screened positive for subthreshold depres-
sive symptoms (Centre for Epidemiological Studies
Depression Scale [CES-D] ≥ 16; Lewinsohn, 1974),
(b) were aged 18 and above, (c) had Internet access,
(d) were not currently receiving or (e) on a waiting
list for psychotherapy for any kind of mental health
problem, (f) had had no psychotherapy for any kind
of mental health disorder in the past 6 months, and
(g) had no notable suicidal risk (BDI item 9 N 1)
were scheduled for a semistructured clinical inter-
view (SCID) conducted by telephone by trainees in
psychotherapy to assess final eligibility. Those
meeting DSM-IV criteria for (a) a major depressive
episode, (b) bipolar disorder, or (c) psychotic
disorder, and (d) having a history of a major
depressive disorder in the past 6 months according
to Kupfer’s model (Kupfer, 1991) were excluded.
According to Kupfer’s model, a patient is considered
to be recovered when he or she stays in remission for
a minimum of 6 months. As we conducted a
pragmatic trial, the use of antidepressant medication
was allowed as part of care-as-usual. However,
participants needed to be on a stable dose for at least
4 weeks to be able to enter the study.
Assessed for eligibility (n = 2244)
Not meeting inclusion criteria (n = 763)
CES-D < 16 (n = 139)
BDI item 9 > 1 (n= 64)
Current psychotherapy (n = 239)
Being on a waiting list (n = 181)
Psychotherapy in past 6 months (n = 106)
Previously diagnosed psychosis (n = 34)
Screened for another study (n = 770)
Screened after study enrolment completed (n =320)
Completed HRSD/QIDS interview (n = 77)
Could not be reached (n = 25)
Completed online questionnaires (n = 81) 
Refused (n = 21)
Allocated to GET.ON Mood Enhancer (n = 102)
- Adhered to treatment protocol (n = 68)
- Did not adhere to protocol (n = 34)
Completed HRSD/QIDS interview (n = 92)
Could not be reached (n = 10)
Completed online questionnaires (n = 97)
Refused (n = 5)
Allocated to waitlist control condition (n = 102)
Randomised (n = 204)
SCIDs conducted (n = 391)
Excluded (n = 187)
- Not meeting inclusion criteria (n = 94)
• Acute MDD (n = 58)
• MDD in the past 6 months (n = 17)
• (Hypo)mania (n = 12)
• Suicidal risk (n = 7)
- Withdrew from participation (n = 36)
- No informed consent / baseline (n= 57) 
Completed online questionnaires (n = 72)
Refused (n = 30)
Completed online questionnaires (n = 91)
Refused (n = 11)





FIGURE 1 Study flow chart.
74 ebert et al .randomization and masking
Participants passing all inclusion and exclusion
criteria who completed the baseline assessment and
returned their informed consent formwere randomlyallocated to study conditions. Randomization took
place at individual level and was conducted centrally
by an independent researcher not otherwise involved
in the study using an automated computer-generated
75web - and mob i le - ba s ed treatment of subthre shold depre s s ionrandom numbers table. Block randomization of size
twelve was used to ensure equity of sample sizes
across study conditions. As usual for psychological
intervention trials, study participants knew their
allocation. The research staff conducting the
observer-based rating of depressive symptom sever-
ity were blind to treatment allocation. Steps to ensure
blindness included the following: (a) an explanation
to participants as towhy it is important not to inform
the interviewer about the condition to which they
were assigned; (b) a written reminder in the interview
manual for the interviewer to ask participants not to
disclose their randomization status; (c) verbal
reminders to participants before the interview; and
(d) a documentation after the assessment of whether
or not the interviewer was still blind to the treatment
condition.
interventions
All study participants had unrestricted access to
routine care (i.e., visits to the GP). According to the
German S3-Guideline/National Disease Manage-
ment Guideline Unipolar Depression, more intensive
psychological interventions (i.e., cognitive behavior-
al therapy) should only be offered if depressive
symptoms intensify (i.e., diagnosed major depressive
disorder) (Bundesärztekammer, Bundesvereinigung,
& Fachgesellschaften, 2011). Following the
S3-Guideline, usual care is then subsequently stepped
up to more intensive interventions (i.e., psychother-
apy or prescription of antidepressant medication). In
this pragmatic trial, usual care was not protocolized.
Participants in the control condition received
access to the web-based intervention 3 months after
randomization.
Web-Based Intervention
Theweb-based intervention consists of six 30-minute
interactive sessions. However, the duration of
sessions might vary across users. Four weeks after
finishing the intervention, participants are offered an
optional booster session. The aim of this session is to
evaluate progress and to strengthen skills acquired
during the intervention. Intervention sessions include
text, exercises, testimonials, and audio and video
clips. Audio sequences introduce relaxation exer-
cises, whereas video clips explain theoretical frame-
works in a user-friendly way. Based on studies
suggesting that a higher treatment session frequency
might be associated with a better outcome (Cuijpers,
Huibers, Ebert, Koole, & Andersson, 2013),
participants were advised to complete two sessions
a week, if possible, but a minimum of at least one.
Intervention usagewasmonitored by logfile analysis.
The intervention is based on behavior therapy (BT)
and problem-solving therapy (PST), the content ofwhich has been described in detail elsewhere by
Buntrock et al. (Buntrock et al., 2015; Buntrock
et al., 2016). A detailed description of the interven-
tion can be found in the supplemental online
material. During the study, a strong emphasis was
placed on homework assignments meant to help the
integration of acquired coping skills into daily life. As
an optional component, participants could choose
to receive a set of roughly 42 standardized text-
messages supporting them in this integration.
During the intervention, participants were sup-
ported by an e-coach applying an adherence-focused
guidance concept. Trained and supervised graduate
students aswell as health care professionals served as
e-coaches and provided guidance. Adherence mon-
itoring included checking whether participants
completed intervention sessions and, if not, remind-
ing them to do so. The e-coach sent reminders if
participants did not complete a sessionwithin 7 days.
Feedback was provided only upon request of the
intervention users as part of a feedback on demand
approach.Within 48 hours, the participants received
personalized written feedback. The feedback provid-
ed by the e-coaches focused on supporting partici-
pants to work through the exercises and no
therapeutic advice was given.
outcomes
Self-report measures were collected at baseline,
posttreatment, and 3-month follow-up. We used a
secured online-based assessment system (AES, 256-bit
encrypted). The diagnostic interviews at baseline and
posttreatment were conducted by telephone.
Primary Outcome
Depressive symptom severity. The primary out-
come was depressive symptom severity as measured
by the 16-item Quick Inventory of Depressive
Symptomatology–Clinician-Rating (QIDS-CR16).
The QIDS-CR16 evaluates the nine depression
criterion symptom domains, as stated in the
DSM-IV, during the prior 7 days, providing a
nuanced understanding of the symptom severity.
Each item is scored on a scale from0 to 3,with higher
scores indicating higher symptom severity. TheQIDS
has shown good psychometric properties, such as
strong internal consistency (α=0.85), concurrent
validity, and sensitivity to symptom change in
patients with major depression (Trivedi et al.,
2004). Cutoff points of 6, 11, 16, and 21 represent
the thresholds for mild, moderate, severe, and very
severe depressive symptom severity, respectively.
Interrater reliability was assessed by rating audio-
taped diagnostic interviews by an independent
experienced diagnostic rater. Interrater reliability
based on data of 10% of participants was 0.97.
76 ebert et al .Secondary Outcomes
Mental health. Among the secondary outcomes
concerning mental health, the following outcomes
were measured using the specified scales: depres-
sion, using the Hamilton Rating Scale for Depres-
sion ([HRSD-24]; interrater reliability 0.94). The
HRSD is a widely used clinician-rated scale for
measuring depression with high internal consisten-
cy (α = .88) and sensitivity to change over time and
treatment. The cutoff points of 10, 19, 27, and 35
indicate the thresholds for mild, moderate, severe,
and very severe depressive symptom severity,
respectively (Rush et al., 2003). Self-reported
depressive symptomatology was measured with
the Center for Epidemiological Studies Depression
Scale (CES-D; Radloff, 1977; 20 items, range 0–60,
α=.78). Using the HRSD and the CES-D allowed
for a more detailed comparison with previous
research. Anxiety, using the anxiety subscale of the
Hospital Anxiety and Depression Scale (HADS-A;
Zigmond & Snaith, 1983; 7 items, range 0–21, α =
.67); worrying, using the ultra-brief version of the
Penn StateWorryQuestionnaire (PSWQ; Berle et al.,
2011; 3 items, range 0–18, α = .84); insomnia
severity, using the Insomnia Severity Index (ISI;
Bastien, Vallieres, & Morin, 2001; 7 items, range
0–28, α = .86); and alcohol use disorders, using the
Alcohol Use Disorders Identification Test (AUDIT;
Saunders, Aasland, Babor, de la Fuente, & Grant,
1993; 10 items, range 0–40, α = .80).
Treatment Mechanism Measures
Behavioral activation, using the Behavioural Activa-
tion for Depression Scale–Short Form (BADS-SF;
Manos, Kanter, & Luo, 2011; 9 items, range 0–56,
α = .68); problem-solving skills in terms of positive
problem orientation, using the positive problem
orientation subscale of the Social Problem-Solving
Inventory-Revised (SPSI-R; D’Zurilla, Nezu, &
Maydeu-Olivares, 2002; 5 items, range 0–20, α =
.77) and negative problem orientation, using the
negative problem orientation subscale of the SPSI-R
(5 items, range 0–20, α = .85); and mastery, using the
Pearlin Mastery Scale (PSMS; Pearlin & Schooler,
1978; 7 items, range 0–21, α = .72) were assessed as
measures of treatment mechanism.
sample size
Based on a meta-analysis of psychological treatments
for subthreshold depression (Cuijpers, Koole, et al.,
2014), this trial was powered to detect a mean
difference ofd=0.35 in the primary outcomebetween
the groups at posttreatment, with an α of 0.05 and a
power of 80% in a one-tailed test. A one-tailed test
was applied based on the unidirectional hypothesis
that the intervention group is superior compared tothe control group. This assumption is supported by
the first trial on this intervention (Buntrock et al.,
2015; Buntrock et al., 2016). Based on the power
calculation, we needed to include 204 participants.
data analyses
All analyses are reported according to theCONSORT
statement (Schulz, Altman, &Moher, 2010). Follow-
ing the intention-to-treat principle, all analyses were
based on the imputed dataset. All analyses were
performedwith IBMSPSS v. 22. All reported p-values
are one-sidedwith a significance level of 0.05.Missing
data were imputed using a Markov Chain Monte
Carlo multivariate imputation algorithm (missing
data module in SPSS 22) with 10 estimations per
missing value. In addition, per protocol analyses were
conducted based on the sample of participants who
adequately adhered to the intervention protocol.
Participants were classified as intervention completers
if they adhered to at least 80% of the intervention
(5 out of 6 sessions). We also performed analyses to
assess whether intervention completers differed from
noncompleters in terms of demographic characteris-
tics or baseline depressive symptom severity. We used
analysis of covariance (ANCOVA) to compare
outcomes between groups at posttreatment and at
3-month follow-up adjusting for baseline scores.
Because income levels were unequally distributed
between study conditions, income was also included
as covariate into the model (post hoc). As income was
not a predictor of the outcome, it was excluded from
the finalmodel. Resultswere reported asmeanwithin-
and between-group differences and asCohen’s d effect
sizes (and their 95% CIs according to Hedges and
Olkin, 1985) controlling for baseline data (i.e.,
calculating change scores divided by the pooled
standard deviation of change scores). Improvements
on the primary outcome at individual level were
examined by assessing the number of participants
who displayed a treatment response and symptom-
free status. Response represented significant symp-
tomatic improvement, whereas symptom-free status
represented improvement to the point of being
asymptomatic within a normal range. In studies of
acute treatment for depression, response is most
consistently defined as at least a 50% reduction in
the symptom score from baseline on a standardized
rating scale (i.e., QIDS and HRSD) (Israel, 2006).
However, in studies of the treatment of subclinical
formsof depression, the reliable change index (RCI) as
proposed by Jacobson and Truax (1991) is often used
to define treatment response (Buntrock et al., 2015;
Haringsma, Engels, Cuijpers, & Spinhoven, 2006;
Spek et al., 2007; Vazquez et al., 2012). Thus, to use
similar criteria across studies and to facilitate com-
parisons, we applied the RCI in addition to the 50%
77web - and mob i le - ba s ed treatment of subthre shold depre s s ionreduction in symptom score from baseline. Partici-
pants were defined as reliably improved if their QIDS
(HRSD) score declined frombaseline to posttreatment
with more than 1.96 standard units, while also taking
into account the reliability of the measurement
instruments to compensate for measurement error.
Participants met criteria for reliable change when they
had improved at least 3.60 points on the QIDS and
4.47 points on the HRSD, respectively. Symptom-free
status was defined a priori as a nonpathological score
of b6 on theQIDS and of b10 on theHRSD24 (Rush
et al., 2003; Trivedi et al., 2004). Patients scoring in
the normal range of the QIDS and HRSD at baseline
were excluded from the analyses. Numbers
needed-to-treat (NNT; with 95% CI) to achieve one
additional response and symptom-free status, respec-
tively, were calculated as the inverse of the risk
difference (Kraemer & Kupfer, 2006). We performed
sensitivity analyses to test whether treatment durationTable 1
Baseline Characteristics According to Study Group (Mean and Stan
Characteristic Intervention group
(n=102)
QIDS sum score 8.17 (3.62)
HRSD sum score 13.72 (6.20)
CES-D sum score 26.67 (6.50)







Married or cohabiting 65 (63.7%)




Not reported 23 (22.5%)
Level of education
Low (primary) 2 (2.0%)
Middle (secondary) 16 (15.7%)
High (A-level or higher) 84 (82.4%)
Employment status
Employed 90 (88.3%)
Unemployed or seeking work 2 (2.0%)
On sick leave 0 (0%)
Non-working 10 (9.8%)
Income in Euro a
Low (b 10.000) 9 (8.8%)
Middle (10 - 60.000) 70 (68.6%)
High (N 60.000) 14 (13.7%)
Not reported 9 (8.8%)
Note. QIDS = Quick Inventory of Depressive Symptomatology. HRSD
Epidemiological Studies Depression Scale.
a Gross annual income.and receiving treatment during the follow-up period
were predictors of the outcome. In addition, primary




Participant characteristics at baseline are shown in
Table 1. In brief, participants were predominantly
female (80.4%), of an average age of 44 years (SD
11.7), had an above-average level of education
(A-level or higher: 81.9%), and were employed
(86.8%). Four out of 10 participants have received
psychotherapy at some point in their lives (n = 82;
40.2%). There were no clinically important differ-
ences between treatment conditions in terms of any
baseline characteristic indicating that randomiza-
tion was successful. Figure 1 illustrates the enroll-





8.11 (3.90) 8.14 (3.75)
14.63 (6.81) 14.17 (6.52)
27.73 (7.50) 27.20 (7.02)
6 (5.9%) 13 (6.4%)
43.75 (11.84) 44.20 (11.73)
20 (19.6%) 40 (19.6%)
82 (80.4%) 164 (80.4%)
28 (27.5%) 55 (27.0%)
53 (52.0%) 118 (57.8%)
20 (19.6%) 29 (14.2%)
1 (1.0%) 2 (1.0%)
81 (79.4%) 160 (78.4%)
21 (20.6%) 44 (21.6%)
3 (2.9%) 5 (2.5%)
16 (15.7%) 32 (15.7%)
83 (81.4%) 167 (81.9%)
87 (85.3%) 177 (86.8%)
4 (3.9%) 6 (2.9%)
2 (2.0%) 2 (1.0%)
9 (8.8%) 19 (9.3%)
25 (24.5%) 34 (16.7%)
59 (57.8%) 129 (63.2%)
10 (9.8%) 24 (11.8%)
8 (7.8%) 17 (8.3%)
= Hamilton Rating Scale for Depression. CES-D = Center for
78 ebert et al .total of 204 participants were included in the study.
Dropout rates differed between study groups at
posttreatment and 3-month follow-up. As can be
seen, dropout was higher in the intervention group
(HRSD/QIDS interview posttreatment: χ2(1) =
7.76, p = .005; online questionnaires posttreatment:
χ2(1) = 11.28, p = .001; online questionnaires
3-month follow-up: χ2(1) = 11.02, p = .001). Study
dropout was not associated with baseline depressive
symptomseverity (p = .92) or any socio-demographic
factor (lowest p-value = .11 for income). However,
study dropout was associated with being in the
intervention group,χ2 (1, n = 204) = 12.57,p b .001.
Eleven participants (5.4%) informed interviewers
about their randomization status during the HRSD/
QIDS follow-up interview (intervention group: 8/102,
7.8%; control group: 3/102, 2.9%).
Intervention Usage, Reminders, and Content
Feedbacks
The average treatment duration was 7 weeks (SD =
3.17) and participants completed on average 5
sessions (SD = 2.25). Out of the 102 participants
who were initially assigned to the intervention, 68
(66.7%) were intervention completers. Of those,
63 (92.6%) adhered to all six sessions. The booster
session was completed by 40 (39.2%) participants.
Of the 34 participants (33.3%) not completing
80% of the intervention, 6 participants never
started the intervention (5.9%). Intervention com-
pleters did not significantly differ from noncompl-
eters with regard to any baseline characteristics
(lowest p-value = .20 for depressive symptom
severity based on the QIDS).
The e-coaches spent on average 30 minutes on
each participant. In total, the e-coaches sent 301
reminders corresponding to a mean of 3.07
reminders per participant (range: 0–9, SD = 2.08).
Interestingly, only a few participants (n = 6, 5.88%)
requested feedback, resulting in 15 content feed-
backs for the entire sample. This corresponds to an
average of 0.15 feedback demands per participant
(range: 0–5, SD = 0.71). Thus, most time spent per
participant was related to checking adherence and
providing reminders.
Primary Intervention Outcome
Table 2 shows means, standard deviations, and
between-group effect sizes of the clinical outcomes
based on the intention-to-treat sample. Both study
groups displayed statistically significant reductions
in depressive symptom severity as indicated by
changes in baseline to posttreatment scores in the
QIDS (Table 2). Based on the QIDS, corresponding
within-group Cohen’s d effect sizes were 0.95
(95% CI 0.66–1.24) for the intervention group
and 0.52 (95%CI 0.24–0.80) for the control group,respectively. As hypothesized, there was a statisti-
cally significant between-group difference in QIDS
scores at posttreatment in favor of the intervention
group, F(1, 201) = 11.31, p = .001. This difference
in QIDS scores corresponded to a small to medium
between-group effect size of 0.37 (95% CI
0.09–0.64). Per protocol analyses showed that
intervention completers did not differ significantly
from noncompleters regarding QIDS scores at
posttreatment, F(1, 99) = .001, p = .99.
Secondary Outcomes
We found a statistically significant between-group
difference in HRSD scores at posttreatment in favor
of the intervention group (HRSD: F[1, 201] = 7.36,
p = .007). This difference in HRSD scores
corresponded to a small between-group effect size
of 0.23 (95% CI -0.05–0.50). There were significant
between-group differences for secondary outcomes
favoring the intervention group except for mastery
(Pearlin Mastery Scale; p = 0.18), negative
problem-orientation (subscale of the SPSI; p =
0.34), and alcohol use (AUDIT; p = 0.10). The effect
sizes of the secondary outcomes ranged fromd =0.41
(95% CI 0.13–0.68) (HADS-A) to d = 0.71 (95%
CI 0.43–0.99) (CES-D) (Table 2).
Response and Symptom-Free Status
Based on the QIDS and HRSD, a score reduction of
50% from baseline to posttreatment was significant-
ly more often seen in participants of the intervention
group (QIDS: 37/102 = 36.3%; HRSD: 34/102 =
33.3%) as compared to the control group (QIDS: 22/
102 = 21.6%; χ2 (1, n = 204) = 5.365, p = 0.015;
HRSD: 19/102 = 18.6%;χ2 (1, n = 204) = 5.735, p =
0.012). This resulted in a NNT of 7 for both QIDS
(95% CI 3.7–41.2) and the HRSD (95% CI
3.8–35.2), respectively, to achieve one additional
treatment response as compared to the control
group. A reliable change from baseline to posttreat-
ment in depressive symptom severity was seen
significantly more often in the intervention group
(QIDS: 46/102, 45.1%; HRSD: 41/102, 40.2%)
comparedwith the control condition (QIDS: 29/102,
28.4%;χ2 (1, n = 204) = 6.09, p = .001; HRSD: 22/
102, 21.6%; χ2 (1, n = 204) = 8.29, p = .004). This
resulted in an NNT of 7 (95% CI 3.4–27.5) based
on the QIDS and 6 (95%CI 3.2–16.1) based on the
HRSD to achieve one additional treatment re-
sponse compared to the control group. Seeing a
reliable improvement was one and a half times to
almost twice as likely in the intervention group
compared to the control condition (QIDS: likeli-
hood ratio = 1.59, 95% CI 1.09–2.31; HRSD:
likelihood ratio = 1.86, 95% CI 1.20–2.89). There
were higher rates of symptom deterioration from
baseline to posttreatment in the control group when
Table 2
Means, SD and Effect Sizes (95% CIs) for the Clinical Outcomes Based on the Imputed Data Set (N=204)
Pre-assessment Post-assessment 3-month FU Between-group effect size
Cohen’s d (95% CI)
Mean SD Mean SD Mean SD pre-post pre-3-month FU
QIDS-C 0.37 (0.09-0.64)
INT 8.18 3.62 4.98 3.11
CTR 8.11 3.89 6.25 3.22
HRSD 0.23 (-0.05-0.50)
INT 13.72 6.21 9.60 5.60
CTR 14.62 6.81 11.59 5.86
CES-D 0.71 (0.43-0.99) 0.66 (0.38-0.95)
INT 26.67 6.50 17.79 7.03 17.32 8.33
CTR 27.73 7.50 24.06 7.85 24.29 8.90
AQoL total score
INT 61.66 7.81 67.53 7.57 69.09 8.58 0.68 (0.39-0.96) 0.68 (0.40-0.96)
CTR 61.03 9.87 62.43 9.81 62.99 10.55
AQoL MCS 0.65 (0.37-0.94) 0.74 (0.45-1.02)
INT 62.18 7.68 67.27 7.40 69.18 8.47
CTR 61.91 10.01 62.80 9.70 63.23 9.90
AQoL PCS 0.55 (0.27-0.83) 0.46 (0.18-0.74)
INT 60.40 9.65 68.17 9.30 68.86 9.96
CTR 58.90 11.04 61.52 11.55 62.37 13.26
HADS-A 0.41 (0.13-0.68) 0.63 (0.35-0.92)
INT 9.63 3.14 8.10 2.98 7.23 3.20
CTR 9.38 3.20 8.78 3.20 8.72 3.52
BADS-SF 0.63 (0.35-0.91) 0.45 (0.17-0.83)
INT 25.70 7.89 32.37 7.34 31.87 7.65
CTR 26.80 6.69 28.65 7.75 29.43 8.31
SPSI-NPO 0.05 (-0.23-0.32) 0.10 (-0.23-0.32)
INT 7.26 4.54 6.54 4.30 5.92 3.93
CTR 6.83 4.82 5.87 4.44 5.69 4.13
SPSI-PPO 0.44 (0.16-0.72) 0.29 (0.01-0.56)
INT 9.45 3.94 10.69 3.54 10.68 3.44
CTR 9.71 3.71 9.83 3.62 10.02 4.04
PSWQ 0.43 (0.15-0.71) 0.53 (0.25-0.81)
INT 9.78 3.92 6.98 3.49 7.00 3.83
CTR 9.77 4.04 8.75 4.32 9.15 4.51
ISI 0.41 (0.14-0.69) 0.54 (0.26-0-82)
INT 12.73 5.46 10.11 5.41 9.40 5.36
CTR 11.92 6.02 11.36 5.89 11.29 6.18
PSMS 0.18 (-0.18-0.45) 0.52 (0.24-0.80)
INT 18.71 3.36 19.54 3.21 20.44 3.46
CTR 19.06 3.15 19.41 3.38 19.36 3.67
AUDIT 0.23 (-0.04-0.51) 0.25 (-0.03-0.53)
INT 4.39 4.28 3.68 3.73 3.57 3.60
CTR 4.34 4.43 3.97 4.53 4.00 4.66
Note. SD = Standard deviation. CI = confidence interval. FU = follow-up. INT = intervention group (n=102). CTR = control group (n=102).
HRSD = Hamilton Rating Scale for Depression. QIDS-C = Quick Inventory of Depressive Symptomatology – Clinician rating. CES-D =
Center for Epidemiological Depression Scale. AQoL = Assessment of Quality of Life. HADS – A = Hospital Anxiety and Depression Scale.
BADS-SF = Behavioural Activation for Depression Scale Short Form. SPSI – NPO = Social Problem-Solving Inventory - negative problem
orientation. SPSI – PPO = Social Problem-Solving Inventory - positive problem orientation. PSWQ = Penn State Worrying Questionnaire
(ultra brief version). ISI = insomnia Severity Index. PSMS = Pearlin Mastery Scale. AUDIT = Alcohol Use Disorders Identification Test.
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not reach statistical significance (QIDS: intervention
group: 3/102, 2.9%; control group: 5/102, 4.9%;
χ2 (1, n = 204) = 0.52, p = .36; HRSD: interven-
tion group: 5/102, 4.9%; control group: 12/102,11.8%; χ2 (1, n = 204) = 3.14, p = .06). Based on
the QIDS and the HRSD, significantly more
participants in the intervention group met the
criteria for symptom-free status (QIDS: 46/78,
59% vs. 26/73, 35.6%; χ2 (1, n = 151) = 8.247,
80 ebert et al .p = 0.003; HRSD: 31/72, 43.1% vs. 22/78,
28.2%; χ2 (1, n = 150) = 3.614, p = 0.042). The
corresponding NNT was 5 for the QIDS (95% CI
2.6-12.7) and 7 for the HRSD (95% CI -3–22.7),
respectively.
Longer-Term Effects
There were no changes in depression symptom
severity from posttreatment to follow-up, neither in
the intervention group, t(101) = -.654, p = .51, nor in
the control group, t(101) = .100, p = .92, indicating
that initially achieved changes from baseline to
posttreatment were sustained over time. ANCOVAs
controlling for baseline depression severity showed a
statistically significant between-group difference in
CES-D scores at follow-up favoring the intervention
group, F(1, 201) = 34.80, p b .001. This difference
corresponded to an effect size of 0.66 (95% CI
0.38–0.95). Between-group differences for second-
ary outcomes were still significant at the 3-month
follow-up except for negative problem-orientation
(subscale of the SPSI; p = .82) and alcohol use
disorders (AUDIT; p = .12).
Sensitivity Analyses
More participants in the control group (6/102,
5.9%) received treatment during the follow-up
period compared to the intervention group (4/102,
3.9%). However, this difference was not statistically
significant, χ2 (1, n = 204) = 0.421, p = .52. Neither
treatment duration (posttreatment: F[1, 99] = .162,
p = .69; 3-month follow-up: F[1, 99] = .341, p =
.56) nor receiving treatment during the follow-up
period (posttreatment F[1, 200] = .302, p = .58;
3-month follow-up: F[1, 200] = .013, p = .91) were
significant predictors of the outcome. Sensitivity
analyses based on the study completers’ sample did
not result in a different interpretation of the
primary intervention outcome, F(1, 166) = 14.59,
p N .001.
Discussion
Findings of the present study support the primary
hypothesis that the intervention resulted, compared
to a nontreated control group, in lower depressive
symptom severity in participants with subthreshold
depression. This finding was replicated both in
self-reported and in two observer-based ratings of
depressive symptom severity. Effects were also
found for a number of relevant secondary outcomes
such as health-related quality of life, worrying,
behavioral activation, anxiety, and sleep problems.
No effects were found for mastery, negative
problem orientation, and comorbid problematic
alcohol use.
The effects observed in the present study are in
line with findings of another recent meta-analysison psychological interventions for subthreshold
depression (Cuijpers, Koole, et al., 2014). More-
over, the current study extends these findings by
showing that a psychological intervention can have
clinically relevant effects on observer-rated depres-
sive symptom severity. Effect sizes on most assessed
outcomes were above the suggested cutoff of a
minimal important difference of a standardized
mean difference of 0.24 in the treatment of
depression (Cuijpers, Turner, et al., 2014). The
number-needed-to-treat (NNT) ranged from be-
tween 5 and 7 to achieve one additional treatment
response or symptom-free status, and depended on
the outcome measure used. Similar numbers are
found for antidepressants in the treatment of major
depression (Guirguis-Blake, 2010). All in all, the
observed effects can be interpreted as clinically
relevant. However, little is known about the actual
impact these effects have on patients’ lives. In
addition, using the same approach applied to
characterize clinically significant change in major
depression may not be valid in subthreshold depres-
sion. It is worth noting that the effect sizes for most
secondary outcomes were similar to those found in
the first RCT evaluating this novel web-based
intervention (Buntrock et al., 2015; Buntrock et al.,
2016). While in the first RCT the intervention was
delivered with substantial human support from a
psychologist (approximately 3 hours per participant),
the present study found clinically meaningful effects
without providing individual written feedback on
each session. The observed difference between
self-report and observer-based depressive symptom
severity is in line with previous research (Cuijpers,
Koole, et al., 2014). However, a meta-analysis on
self-reported versus clinician-rated symptoms of
depression showed a higher effect size for clinician-
rated instruments as compared to self-report instru-
ments (Cuijpers, Li, Hofmann, & Andersson, 2010).
Depending on the symptom severity of an individual,
self-report or clinician ratings might bemore suitable.
Therefore, it seems best to include both kinds of
assessment in clinical research.
Other key findings of our study can be summa-
rized as follows. First, effects on self-reported
depression severity were large in size, which further
supports the potential benefits of treating depres-
sive symptoms at a very early disease stage. Studies
on the prevention of depression indicate that the
treatment of subthreshold depression may not only
reduce symptom severity, but may also help to
prevent further deterioration of symptoms and
prevent the onset of a full-blown major depression
(Buntrock et al., 2016; van Zoonen et al., 2014).
Second, our study shows that clinically important
results can be achieved in a less intensive guidance
81web - and mob i le - ba s ed treatment of subthre shold depre s s ionformat. Instead of providing detailed feedback after
each completed session, the e-coach simply moni-
tored the adherence to the intervention and only
provided feedback on the content on request of
participants. Surprisingly few participants asked for
content feedback: 15 in 102 participants, averaging
at 0.15 feedbacks per participant. The e-coaches
spent on average 30 minutes on each participant,
and most of the resources spent for coaching were
utilized to monitor the adherence to the interven-
tion. Hence, the question arises whether or not
automated reminders, in combination with feed-
back on demand, have a similar effect while
requiring even fewer resources. Although 3 hours
of psychological support per participant is already
much less than in individual face-to-face CBT
interventions, even more patients with subthreshold
depression could be treated for the same costs if
meaningful results are achieved using less thera-
pists’ time. Third, noncompleters did not differ
from intervention completers regarding QIDS
scores at posttreatment. This might be an indication
that intervention dropout might not necessarily be
related to treatment success. Participants might not
proceed with the intervention because they already
achieved sufficient improvements. However, more
research is needed to support such an assumption
and to explore the relationship between treatment
dropout and success in web-based interventions for
(subthreshold) depression. Fourth, the large effects
found in the present study are in line with the
assumption that higher effect sizes frequently found
for guided vs. unguided self-help interventions
(Baumeister, Reichler, Munzinger, & Lin, 2014)
are attributable to the adherence-promoting factor of
human support. This has also been stated previously
in the supportive accountability model of human
support in Web-based intervention (Mohr et al.,
2011). However, randomized controlled trials that
compare adherence-focused guidance format with
regular content feedbacks are needed to support such
an assumption and to determine whether or not
adherence-focused guidance formats result in out-
comes equivalent to those of more intensive
content-focused guidance formats. Even if a less
intensive guidance format should yield lower effects
in direct comparisons, their potential on a population
level might still be higher, as such interventions can
be distributed tomore participants for a given budget
of health care resources. On the other hand, it may
very well be the case that patients with subthreshold
depression are less willing to participate in inter-
ventions in which no regular content-feedback
from a health care provider is offered, which would
result in a lower reach and thus lower overall
effects in the target population. Thus, future studiesshould compare the acceptability, effectiveness, cost-
effectiveness, and reach of different guidance formats
for subthreshold depression.
This study has the following limitations. First, we
cannot rule out a potential selection bias while
recruiting participants. Moreover, participants in
our study were predominantly female. Hence,
conclusions from the present study may not
generally apply, for example, to population seg-
ments recruited by different recruitment strategies
(i.e., patients recruited in primary or secondary
mental health care). However, this is a common
finding in web-based intervention trials (Andersson
& Titov, 2014), indicating that results may
generally apply to a population that is interested
in web-based interventions. Future studies that
apply different recruitment strategies for the eval-
uation of web-based interventions for subthreshold
depression (i.e., with referral from general practi-
tioners) are needed. Second, participants were not
blind to the study group they were allocated to.
Third, the lack of long-term follow-up and assess-
ment of progression to a full-blown major depres-
sive disorder is a limitation to the study. Future
studies should include a longer-term follow-up to
assess the preventive effects of web-based interven-
tions with adherence-focused guidance. Fourth, we
also did not assess whether participants fulfilled
criteria for an anxiety disorder at baseline. Patients
with comorbid anxiety disorder might benefit to a
different extent from the intervention compared to
those without, which should be investigated in
future studies. Fifth, the study may have benefited
from an inclusion of physiological measures. Future
studies could consider complementing self-reports
and observer-based instruments with objective
measurements (such as inflammatory markers).
Sixth, we did not monitor changes in medication
during the trial period; hence, we cannot rule out
that this might have biased the results. Seventh,
although the current study replicated the results of
the first RCT on this newly developed intervention,
future studies are needed to reliably estimate the
potential effects of web-based interventions for
subthreshold depression in different target popula-
tions (e.g., in individuals with comorbid chronic
conditions or problematic substance use; Schaub
et al., 2016). Eighth, although patients in the control
group had full access to treatment as usual,we cannot
rule out a potential nocebo effect in the control
condition (Furukawa et al., 2014). Finally, although
the majority of the participants reached a symptom-
free status during the trial, a substantial number of
participants did not. Hence, future studies should
investigate whether these participants would profit
from other forms of treatments, such as face-to-face
82 ebert et al .psychotherapy or antidepressant medication, and
whether it is possible to identify these individuals on
an individual level on the basis of amultivariate set of
baseline predictors (Kessler, van Loo, Wardenaar,
Bossarte, Brenner, Cai, et al., 2016; Kessler, van Loo,
Wardenaar, Bossarte, Brenner, Ebert, et al., 2016).
The use of scalable web-based interventions based
on recent advancements, such as advantages in
machine-learning techniques, may help to obtain
large enough sample sizes that are necessary to
overcome the statistical power problem in the
development of such prediction algorithms.
In conclusion, the present study adds to the
growing evidence base that psychological interven-
tions can result in substantial benefits for individuals
with subthreshold depressive symptoms. Moreover,
the present study further adds to the growing
evidence base that web-based guided self-help has a
high potential for delivering effective low-threshold
mental health interventions. Results of the present
study also indicate that web-based interventions for
subthreshold depression can be delivered with
limited human support without a substantial loss of
effects, thus potentially reaching a much greater
population at the same cost as interventions with
more intensive human support.
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